BioAtla, Inc. (BCAB)
OTCMKTS · Delayed Price · Currency is USD
1.260
-0.060 (-4.55%)
At close: Sep 8, 2026
BioAtla Market Cap
BioAtla has a market cap or net worth of $2.1 million as of September 9, 2026. Its market cap has decreased by -93.34% in one year.
Market Cap
2.10M
Enterprise Value
6.42M
Revenue
8.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.26
ChartMarket Cap Chart
Since December 16, 2020, BioAtla's market cap has decreased from 9.78B to 2.10M, a decrease of -99.98%. That is a compound annual growth rate of -77.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 2.10M | -93.74% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 3.15M |
| Affymax | 3.10M |
| Eastgate Biotech | 2.86M |
| AccuStem Sciences | 2.57M |
| Enzolytics | 2.42M |
| Bioxytran | 2.41M |
| VitaSpring Biomedical | 2.30M |
| Vaccinex | 2.01M |